Galleon ships in Merck figureheads
This article was originally published in Scrip
Executive Summary
Galleon Pharmaceuticals has appointed Dr Euan MacIntyre senior vice-president of drug discovery, and Dr James McLeod senior vice-president of clinical research & development and chief medical officer. Dr MacIntyre was previously senior vice-president and head of drug discovery at Arete Therapeutics and vice-president of basic research-pharmacology at Merck & Co. Dr McLeod previously managed the experimental medicine group at Merck Research Laboratories.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.